Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Hydrocortisone for Shock in Preterm Neonates
NCT07248761Phase 4Active, not recruiting
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Feb 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone in Shock, sponsored by Coordinación de Investigación en Salud. Started Feb 2025; status: active, not recruiting.
02
Drugs
hydrocortisone
03
Conditions
Shock
Beyond the preview
Go deeper on NCT07248761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07248761.